
Ashish M. Kamat, MD, MBBS
@urodocash
Endowed Professor, Surgeon, Former Fellowship Director @MDAndersonNews | President, IBCG | Assoc Editor @EurUrolOncol | Views my own
ID: 124649482
http://faculty.mdanderson.org/Ashish_Kamat/Default.asp 20-03-2010 03:23:48
9,9K Tweet
11,11K Takipçi
796 Takip Edilen

Wei Shen Tan Roberto Contieri The latest validation came in 2025 from the Ospedale San Raffaele group Marco Moschini, which applied IBCG risk factors to 174 IR-NMIBC patients eligible for AS Key findings: 🔹 3-year recurrence-free survival (RFS): ✅ 86% for 0 risk factors ⚠️ 76% for 1-2 risk factors 🚨 54% for ≥3
